FibroGen
FGEN
FGEN
29 hedge funds and large institutions have $5.62M invested in FibroGen in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-25
Holders Change %
-46.3%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
16
Closed
28
Calls
$1.82M
Puts
$306K
Net Calls
+$1.51M
Net Calls Change
+$1.37M
Top Buyers
1 |
HighTower Advisors
Chicago,
Illinois
|
+$125K |
2 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$79.5K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.54K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.2K |
5 |
UBS Group
Zurich,
Switzerland
|
+$2.46K |
Top Sellers
1 |
Primecap Management
Pasadena,
California
|
-$318K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$299K |
3 |
Two Sigma Advisers
New York
|
-$210K |
4 |
Millennium Management
New York
|
-$137K |
5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$109K |